Share this Women in Big Law Making an Impact WILEF Tribune June 29, 2016 "Cooley’s Barbara Borden is leading a team representing Jazz Pharmaceuticals in its $1.5 billion acquisition of Celator Pharmaceuticals, the maker of a treatment for acute myeloid leukemia." Read the article here.
"Cooley’s Barbara Borden is leading a team representing Jazz Pharmaceuticals in its $1.5 billion acquisition of Celator Pharmaceuticals, the maker of a treatment for acute myeloid leukemia." Read the article here.